These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34699318)

  • 21. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
    Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
    Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ING4 suppresses tumor angiogenesis and functions as a prognostic marker in human colorectal cancer.
    Chen Y; Huang Y; Hou P; Zhang Z; Zhang Y; Wang W; Sun G; Xu L; Zhou J; Bai J; Zheng J
    Oncotarget; 2016 Nov; 7(48):79017-79031. PubMed ID: 27806345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long Noncoding RNA PVT1 Promotes Non-Small Cell Lung Cancer Cell Proliferation through Epigenetically Regulating LATS2 Expression.
    Wan L; Sun M; Liu GJ; Wei CC; Zhang EB; Kong R; Xu TP; Huang MD; Wang ZX
    Mol Cancer Ther; 2016 May; 15(5):1082-94. PubMed ID: 26908628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.
    Shi H; Zhou Y; Liu H; Chen C; Li S; Li N; Li X; Zhang X; Zhang H; Wang W; Zhao Q
    BMC Cancer; 2010 Sep; 10():477. PubMed ID: 20815902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-372 is associated with poor prognosis in colorectal cancer.
    Yamashita S; Yamamoto H; Mimori K; Nishida N; Takahashi H; Haraguchi N; Tanaka F; Shibata K; Sekimoto M; Ishii H; Doki Y; Mori M
    Oncology; 2012; 82(4):205-12. PubMed ID: 22456107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
    Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of microRNA-16 expression in human colorectal cancer.
    Qian J; Jiang B; Li M; Chen J; Fang M
    World J Surg; 2013 Dec; 37(12):2944-9. PubMed ID: 24045965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
    Yang C; Cao F; Huang S; Zheng Y
    Front Immunol; 2021; 12():717505. PubMed ID: 34335633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
    Wang D; Xu MR; Wang T; Li T; Zhu Jw
    J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
    Yue ZW; Liu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
    [No Abstract]   [Full Text] [Related]  

  • 35. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
    Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
    Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer.
    Lee JL; Roh SA; Kim CW; Kwon YH; Ha YJ; Kim SK; Kim SY; Cho DH; Kim YS; Kim JC
    World J Gastroenterol; 2019 Mar; 25(11):1341-1354. PubMed ID: 30918427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification.
    Huang Z; Hu X; Wei Y; Lai Y; Qi J; Pang J; Huang K; Li H; Cai P
    PLoS One; 2024; 19(5):e0303909. PubMed ID: 38814950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
    Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
    World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer.
    Liao R; Ma QZ; Zhou CY; Li JJ; Weng NN; Yang Y; Zhu Q
    Bioengineered; 2021 Dec; 12(1):1676-1688. PubMed ID: 33960283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.
    Yao F; Liu H; Li Z; Zhong C; Fang W
    Tumour Biol; 2015 Mar; 36(3):2049-57. PubMed ID: 25391426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.